Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines.

Huergo-Zapico L, Parodi M, Cantoni C, Lavarello C, Fernández-Martínez JL, Petretto A, DeAndrés-Galiana EJ, Balsamo M, López-Soto A, Pietra G, Bugatti M, Munari E, Marconi M, Mingari MC, Vermi W, Moretta L, González S, Vitale M.

Cancer Res. 2018 Jul 15;78(14):3913-3925. doi: 10.1158/0008-5472.CAN-17-1891. Epub 2018 May 11.

PMID:
29752261
2.

Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells.

Hammer Q, Rückert T, Borst EM, Dunst J, Haubner A, Durek P, Heinrich F, Gasparoni G, Babic M, Tomic A, Pietra G, Nienen M, Blau IW, Hofmann J, Na IK, Prinz I, Koenecke C, Hemmati P, Babel N, Arnold R, Walter J, Thurley K, Mashreghi MF, Messerle M, Romagnani C.

Nat Immunol. 2018 May;19(5):453-463. doi: 10.1038/s41590-018-0082-6. Epub 2018 Apr 9.

PMID:
29632329
3.

A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.

Sullivan LC, Walpole NG, Farenc C, Pietra G, Sum MJW, Clements CS, Lee EJ, Beddoe T, Falco M, Mingari MC, Moretta L, Gras S, Rossjohn J, Brooks AG.

J Biol Chem. 2017 Dec 22;292(51):21149-21158. doi: 10.1074/jbc.M117.807719. Epub 2017 Sep 25.

PMID:
28972140
4.

The Ca2+-activated Cl- channel TMEM16B regulates action potential firing and axonal targeting in olfactory sensory neurons.

Pietra G, Dibattista M, Menini A, Reisert J, Boccaccio A.

J Gen Physiol. 2016 Oct;148(4):293-311. doi: 10.1085/jgp.201611622. Epub 2016 Sep 12.

5.

Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function.

Manzini C, Venè R, Cossu I, Gualco M, Zupo S, Dono M, Spagnolo F, Queirolo P, Moretta L, Mingari MC, Pietra G.

Oncotarget. 2016 Sep 20;7(38):60858-60871. doi: 10.18632/oncotarget.11504.

6.

Human NK cells: From surface receptors to clinical applications.

Moretta L, Pietra G, Vacca P, Pende D, Moretta F, Bertaina A, Mingari MC, Locatelli F, Moretta A.

Immunol Lett. 2016 Oct;178:15-9. doi: 10.1016/j.imlet.2016.05.007. Epub 2016 May 13.

PMID:
27185471
7.

Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition.

Saunders PM, Pymm P, Pietra G, Hughes VA, Hitchen C, O'Connor GM, Loiacono F, Widjaja J, Price DA, Falco M, Mingari MC, Moretta L, McVicar DW, Rossjohn J, Brooks AG, Vivian JP.

J Exp Med. 2016 May 2;213(5):791-807. doi: 10.1084/jem.20152023. Epub 2016 Apr 4.

8.

Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment.

Parodi M, Pedrazzi M, Cantoni C, Averna M, Patrone M, Cavaletto M, Spertino S, Pende D, Balsamo M, Pietra G, Sivori S, Carlomagno S, Mingari MC, Moretta L, Sparatore B, Vitale M.

Oncoimmunology. 2015 May 29;4(12):e1052353. eCollection 2015 Dec.

9.

Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.

Orecchia P, Conte R, Balza E, Pietra G, Mingari MC, Carnemolla B.

Oncotarget. 2015 Nov 10;6(35):37426-42. doi: 10.18632/oncotarget.6055.

10.

Role of NK cells in immunotherapy and virotherapy of solid tumors.

Cantoni C, Grauwet K, Pietra G, Parodi M, Mingari MC, Maria AD, Favoreel H, Vitale M.

Immunotherapy. 2015;7(8):861-82. doi: 10.2217/imt.15.53. Epub 2015 Aug 28. Review.

PMID:
26314197
11.

Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias.

Pietra G, Vitale C, Pende D, Bertaina A, Moretta F, Falco M, Vacca P, Montaldo E, Cantoni C, Mingari MC, Moretta A, Locatelli F, Moretta L.

Cancer Immunol Immunother. 2016 Apr;65(4):465-76. doi: 10.1007/s00262-015-1744-y. Epub 2015 Aug 20. Review.

PMID:
26289090
12.

Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines.

Caccamo N, Pietra G, Sullivan LC, Brooks AG, Prezzemolo T, La Manna MP, Di Liberto D, Joosten SA, van Meijgaarden KE, Di Carlo P, Titone L, Moretta L, Mingari MC, Ottenhoff TH, Dieli F.

Eur J Immunol. 2015 Apr;45(4):1069-81. doi: 10.1002/eji.201445193. Epub 2015 Feb 17.

13.

Circuit formation and function in the olfactory bulb of mice with reduced spontaneous afferent activity.

Lorenzon P, Redolfi N, Podolsky MJ, Zamparo I, Franchi SA, Pietra G, Boccaccio A, Menini A, Murthy VN, Lodovichi C.

J Neurosci. 2015 Jan 7;35(1):146-60. doi: 10.1523/JNEUROSCI.0613-14.2015.

14.

Predictors of carotid occlusion intolerance during proximal protected carotid artery stenting.

Giugliano G, Stabile E, Biamino G, Petroni G, Sannino A, Brevetti L, Pucciarelli A, Popusoi G, Tesorio T, Cioppa A, Cota L, Salemme L, Sorropago A, Ausania A, Della Pietra G, Fontanelli A, Trimarco B, Esposito G, Rubino P.

JACC Cardiovasc Interv. 2014 Nov;7(11):1237-44. doi: 10.1016/j.jcin.2014.05.021. Epub 2014 Oct 15.

15.

Effect of tumor cells and tumor microenvironment on NK-cell function.

Vitale M, Cantoni C, Pietra G, Mingari MC, Moretta L.

Eur J Immunol. 2014 Jun;44(6):1582-92. doi: 10.1002/eji.201344272. Review.

16.

Human NK cells: from surface receptors to the therapy of leukemias and solid tumors.

Moretta L, Pietra G, Montaldo E, Vacca P, Pende D, Falco M, Del Zotto G, Locatelli F, Moretta A, Mingari MC.

Front Immunol. 2014 Mar 7;5:87. doi: 10.3389/fimmu.2014.00087. eCollection 2014. Review.

17.

Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.

Giannoni P, Pietra G, Travaini G, Quarto R, Shyti G, Benelli R, Ottaggio L, Mingari MC, Zupo S, Cutrona G, Pierri I, Balleari E, Pattarozzi A, Calvaruso M, Tripodo C, Ferrarini M, de Totero D.

Haematologica. 2014 Jun;99(6):1078-87. doi: 10.3324/haematol.2013.091405. Epub 2014 Feb 21.

18.

Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC.

Balsamo M, Manzini C, Pietra G, Raggi F, Blengio F, Mingari MC, Varesio L, Moretta L, Bosco MC, Vitale M.

Eur J Immunol. 2013 Oct;43(10):2756-64. doi: 10.1002/eji.201343448. Epub 2013 Aug 5.

19.

Reliability of the modified Rankin Scale applied by telephone.

Savio K, Pietra GL, Oddone E, Reggiani M, Leone MA.

Neurol Int. 2013 Feb 19;5(1):e2. doi: 10.4081/ni.2013.e2. Print 2013 Feb 11.

20.

The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production.

Laurent S, Queirolo P, Boero S, Salvi S, Piccioli P, Boccardo S, Minghelli S, Morabito A, Fontana V, Pietra G, Carrega P, Ferrari N, Tosetti F, Chang LJ, Mingari MC, Ferlazzo G, Poggi A, Pistillo MP.

J Transl Med. 2013 May 1;11:108. doi: 10.1186/1479-5876-11-108.

21.

Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.

Heatley SL, Pietra G, Lin J, Widjaja JM, Harpur CM, Lester S, Rossjohn J, Szer J, Schwarer A, Bradstock K, Bardy PG, Mingari MC, Moretta L, Sullivan LC, Brooks AG.

J Biol Chem. 2013 Mar 22;288(12):8679-90. doi: 10.1074/jbc.M112.409672. Epub 2013 Jan 18.

22.

Melanoma immunoediting by NK cells.

Balsamo M, Pietra G, Vermi W, Moretta L, Mingari MC, Vitale M.

Oncoimmunology. 2012 Dec 1;1(9):1607-1609.

23.

How melanoma cells inactivate NK cells.

Pietra G, Vitale M, Moretta L, Mingari MC.

Oncoimmunology. 2012 Sep 1;1(6):974-975.

24.

Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor.

Balsamo M, Vermi W, Parodi M, Pietra G, Manzini C, Queirolo P, Lonardi S, Augugliaro R, Moretta A, Facchetti F, Moretta L, Mingari MC, Vitale M.

Eur J Immunol. 2012 Jul;42(7):1833-42. doi: 10.1002/eji.201142179. Epub 2012 May 25.

25.

Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.

Pietra G, Manzini C, Rivara S, Vitale M, Cantoni C, Petretto A, Balsamo M, Conte R, Benelli R, Minghelli S, Solari N, Gualco M, Queirolo P, Moretta L, Mingari MC.

Cancer Res. 2012 Mar 15;72(6):1407-15. doi: 10.1158/0008-5472.CAN-11-2544. Epub 2012 Jan 18.

26.

Environmental enrichment decreases GABAergic inhibition and improves cognitive abilities, synaptic plasticity, and visual functions in a mouse model of Down syndrome.

Begenisic T, Spolidoro M, Braschi C, Baroncelli L, Milanese M, Pietra G, Fabbri ME, Bonanno G, Cioni G, Maffei L, Sale A.

Front Cell Neurosci. 2011 Dec 23;5:29. doi: 10.3389/fncel.2011.00029. eCollection 2011.

27.

Validity and reliability of the Barthel index administered by telephone.

Della Pietra GL, Savio K, Oddone E, Reggiani M, Monaco F, Leone MA.

Stroke. 2011 Jul;42(7):2077-9. doi: 10.1161/STROKEAHA.111.613521. Epub 2011 Apr 28.

PMID:
21527755
28.

Visual perceptual learning induces long-term potentiation in the visual cortex.

Sale A, De Pasquale R, Bonaccorsi J, Pietra G, Olivieri D, Berardi N, Maffei L.

Neuroscience. 2011 Jan 13;172:219-25. doi: 10.1016/j.neuroscience.2010.10.078. Epub 2010 Nov 4.

PMID:
21056088
29.

The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.

Pietra G, Romagnani C, Manzini C, Moretta L, Mingari MC.

J Biomed Biotechnol. 2010;2010:907092. doi: 10.1155/2010/907092. Epub 2010 Jun 22. Review.

30.

Proximal endovascular occlusion for carotid artery stenting: results from a prospective registry of 1,300 patients.

Stabile E, Salemme L, Sorropago G, Tesorio T, Nammas W, Miranda M, Popusoi G, Cioppa A, Ambrosini V, Cota L, Petroni G, Della Pietra G, Ausania A, Fontanelli A, Biamino G, Rubino P.

J Am Coll Cardiol. 2010 Apr 20;55(16):1661-7. doi: 10.1016/j.jacc.2009.11.079.

31.

Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity.

Balsamo M, Scordamaglia F, Pietra G, Manzini C, Cantoni C, Boitano M, Queirolo P, Vermi W, Facchetti F, Moretta A, Moretta L, Mingari MC, Vitale M.

Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20847-52. doi: 10.1073/pnas.0906481106. Epub 2009 Nov 23.

32.

HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.

Pietra G, Romagnani C, Moretta L, Mingari MC.

Curr Pharm Des. 2009;15(28):3336-44. Review.

PMID:
19860683
33.

Natural killer cells kill human melanoma cells with characteristics of cancer stem cells.

Pietra G, Manzini C, Vitale M, Balsamo M, Ognio E, Boitano M, Queirolo P, Moretta L, Mingari MC.

Int Immunol. 2009 Jul;21(7):793-801. doi: 10.1093/intimm/dxp047. Epub 2009 Jun 2.

PMID:
19491215
34.

Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5.

Sensi M, Pietra G, Molla A, Nicolini G, Vegetti C, Bersani I, Millo E, Weiss E, Moretta L, Mingari MC, Anichini A.

Int Immunol. 2009 Mar;21(3):257-68. doi: 10.1093/intimm/dxn141. Epub 2009 Jan 30.

PMID:
19181932
35.

Bistatic radar configuration for soil moisture retrieval: analysis of the spatial coverage.

Pierdicca N, De Titta L, Pulvirenti L, Della Pietra G.

Sensors (Basel). 2009;9(9):7250-65. doi: 10.3390/s90907250. Epub 2009 Sep 10.

36.

Purification and HPLC-MS analysis of a naturally processed HCMV-derived peptide isolated from the HEK-293T/HLA-E+/Ul40+ cell transfectants and presented at the cell surface in the context of HLA-E.

Millo E, Pietra G, Armirotti A, Vacca P, Mingari MC, Moretta L, Damonte G.

J Immunol Methods. 2007 Apr 30;322(1-2):128-36. Epub 2007 Feb 21.

PMID:
17331531
37.

Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function.

Vacca P, Pietra G, Falco M, Romeo E, Bottino C, Bellora F, Prefumo F, Fulcheri E, Venturini PL, Costa M, Moretta A, Moretta L, Mingari MC.

Blood. 2006 Dec 15;108(13):4078-85. Epub 2006 Aug 24.

38.

Structural basis for a major histocompatibility complex class Ib-restricted T cell response.

Hoare HL, Sullivan LC, Pietra G, Clements CS, Lee EJ, Ely LK, Beddoe T, Falco M, Kjer-Nielsen L, Reid HH, McCluskey J, Moretta L, Rossjohn J, Brooks AG.

Nat Immunol. 2006 Mar;7(3):256-64. Epub 2006 Feb 12.

PMID:
16474394
39.

Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion.

Mazzarino P, Pietra G, Vacca P, Falco M, Colau D, Coulie P, Moretta L, Mingari MC.

Eur J Immunol. 2005 Nov;35(11):3240-7.

40.

[Guidelines on diagnosis and treatment of pulmonary arterial hypertension].

Galiè N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G; Grupo de Trabajo sobre el diagnóstico y tratamiento de la Hipertensión Arterial Pulmonar de la Sociedad Europea de Cardiología.

Rev Esp Cardiol. 2005 May;58(5):523-66. Spanish. No abstract available.

41.

Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors.

Mingari MC, Pietra G, Moretta L.

Curr Opin Immunol. 2005 Jun;17(3):312-9. Review.

PMID:
15886123
42.

Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.

Galiè N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, Humbert M, Naeije R, Pepke-Zaba J; Task Force.

Eur Heart J. 2004 Dec;25(24):2243-78. No abstract available.

PMID:
15589643
43.

DMBT1 expression is down-regulated in breast cancer.

Braidotti P, Nuciforo PG, Mollenhauer J, Poustka A, Pellegrini C, Moro A, Bulfamante G, Coggi G, Bosari S, Pietra GG.

BMC Cancer. 2004 Aug 9;4:46.

44.

Pathologic assessment of vasculopathies in pulmonary hypertension.

Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, Reid LM, Tuder RM.

J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):25S-32S. Review.

45.

HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.

Romagnani C, Pietra G, Falco M, Mazzarino P, Moretta L, Mingari MC.

Hum Immunol. 2004 May;65(5):437-45.

PMID:
15172443
46.

Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells.

Pietra G, Romagnani C, Mazzarino P, Millo E, Moretta L, Mingari MC.

Eur J Immunol. 2003 Dec;33(12):3427-32.

47.

HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes.

Pietra G, Romagnani C, Mazzarino P, Falco M, Millo E, Moretta A, Moretta L, Mingari MC.

Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10896-901. Epub 2003 Sep 5.

48.

NK-CTLs, a novel HLA-E-restricted T-cell subset.

Moretta L, Romagnani C, Pietra G, Moretta A, Mingari MC.

Trends Immunol. 2003 Mar;24(3):136-43. Review. No abstract available.

PMID:
12615209
49.

Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.

Romagnani C, Pietra G, Falco M, Millo E, Mazzarino P, Biassoni R, Moretta A, Moretta L, Mingari MC.

Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11328-33. Epub 2002 Aug 7.

50.

Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigration.

Christofidou-Solomidou M, Kennel S, Scherpereel A, Wiewrodt R, Solomides CC, Pietra GG, Murciano JC, Shah SA, Ischiropoulos H, Albelda SM, Muzykantov VR.

Am J Pathol. 2002 Mar;160(3):1155-69.

Supplemental Content

Loading ...
Support Center